Attar Eyal C.
SEC CIK 1789076 · EDGAR
BoughtSold
Most active insiders at VOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | — | $55.62M |
| 2 | Reprogrammed Interchange LLC | 10% | — | $15.80M |
| 3 | Shah Rajeev M. | Dir, 10% | — | $13.71M |
| 4 | Kolchinsky Peter | Dir, 10% | — | $10.37M |
| 5 | RA Capital Nexus Fund, L.P. | Dir | — | $3.43M |
| 6 | Mahatme Sandesh | CFO | — | — |
Attar Eyal C. made no open-market trades at VOR in the last 12 months.
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | 2025-02-13 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | S - Sale | $1.42 | -2,227 | 126.6K | -2% | -$3,162 | |
| 2025-02-12 | 2025-02-10 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | S - Sale | $1.37 | -2,554 | 128.9K | -2% | -$3,499 | |
| 2025-02-07 | 2025-02-06 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $1.50 | -1,180 | 131.4K | -0.9% | -$1,770 | |
| D | 2025-02-05 | 2025-02-03 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | A - Grant | $0.00 | +52.5K | 132.6K | +66% | $0 |
| D | 2025-02-05 | 2025-02-03 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $1.34 | -1,353 | 80.1K | -2% | -$1,813 |
| 2024-12-31 | 2024-12-27 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | S - Sale | $1.25 | -10.3K | 81.4K | -11% | -$12.9K | |
| 2024-11-08 | 2024-11-06 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $0.86 | -999 | 91.8K | -1% | -$859.14 | |
| 2024-11-05 | 2024-11-01 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $0.8 | -1,146 | 92.8K | -1% | -$916.80 | |
| 2024-08-08 | 2024-08-06 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $0.87 | -999 | 93.9K | -1% | -$869.13 | |
| 2024-08-05 | 2024-08-01 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $0.94 | -1,146 | 94.9K | -1% | -$1,077 | |
| 2024-06-04 | 2024-06-03 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | S - Sale | $1.39 | -14.6K | 96.1K | -13% | -$20.4K | |
| 2024-05-07 | 2024-05-06 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $1.75 | -999 | 110.7K | -0.9% | -$1,748 | |
| 2024-05-03 | 2024-05-01 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $1.77 | -1,146 | 111.7K | -1% | -$2,028 | |
| 2024-02-08 | 2024-02-06 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $2.32 | -1,180 | 112.9K | -1% | -$2,738 | |
| D | 2024-01-31 | 2024-01-29 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief MEDICAL Off | A - Grant | $0.00 | +62.5K | 114.0K | +121% | $0 |
| 2023-11-08 | 2023-11-06 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief Medical Off | F - Tax | $1.82 | -999 | 51.5K | -2% | -$1,818 | |
| 2023-08-09 | 2023-08-07 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief Medical Off | F - Tax | $2.67 | -999 | 52.5K | -2% | -$2,667 | |
| 2023-05-10 | 2023-05-08 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief Medical Off | F - Tax | $4.14 | -969 | 53.5K | -2% | -$4,012 | |
| D | 2023-02-08 | 2023-02-06 | VOR | Vor Biopharma Inc. | Attar Eyal C. | Chief Medical Off | A - Grant | $0.00 | +54.5K | 54.5K | New | $0 |
| 2022-06-07 | 2022-06-03 | APRE | Aprea Therapeutics, Inc. | Attar Eyal C. | SVP, Chief Medical Off, Dir | F - Tax | $0.81 | -32.7K | 57.2K | -36% | -$26.5K | |
| D | 2022-03-14 | 2022-03-10 | APRE | Aprea Therapeutics, Inc. | Attar Eyal C. | SVP, Chief Medical Off, Dir | A - Grant | $0.00 | +42.9K | 89.9K | +91% | $0 |
| 2022-03-01 | 2022-02-28 | APRE | Aprea Therapeutics, Inc. | Attar Eyal C. | SVP, Chief Medical Off | S - Sale | $1.73 | -36.0K | 47.0K | -43% | -$62.3K | |
| 2021-09-20 | 2021-09-16 | APRE | Aprea Therapeutics, Inc. | Attar Eyal C. | SVP, Chief Medical Off | S - Sale | $4.68 | -16.0K | 83.0K | -16% | -$74.7K | |
| 2021-08-27 | 2021-08-25 | APRE | Aprea Therapeutics, Inc. | Attar Eyal C. | SVP, Chief Medical Off | F - Tax | $3.98 | -9,032 | 99.0K | -8% | -$35.9K |
Purchase Sale Sale after option exercise All abbreviations